ProfileGDS4718 / 200962_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 76% 74% 85% 62% 81% 72% 84% 81% 75% 66% 78% 79% 90% 85% 90% 82% 85% 83% 91% 86% 73% 78% 71% 83% 70% 82% 73% 92% 81% 80% 83% 89% 75% 78% 86% 95% 84% 80% 81% 87% 82% 76% 85% 75% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.4471376
GSM549102patient 115, normal, homogenized [OPG study]7.1884874
GSM549104patient 119, normal, homogenized [OPG study]8.499785
GSM549108patient 138, normal, homogenized [OPG study]6.2584762
GSM549119patient 077, normal, homogenized [OPG study]7.9458181
GSM549133patient 032, cancer, homogenized [OPG study]7.156572
GSM549139patient 042, cancer, homogenized [OPG study]8.3593284
GSM549099patient 107, normal, homogenized [OPG study]7.8326581
GSM549109patient 139, normal, homogenized [OPG study]7.2583175
GSM549110patient 046, normal, homogenized [OPG study]6.5630666
GSM549114patient 063, normal, homogenized [OPG study]7.6592578
GSM549122patient 082, normal, homogenized [OPG study]7.7416779
GSM549134patient 033, cancer, homogenized [OPG study]9.1392390
GSM549136patient 036, cancer, homogenized [OPG study]8.5325985
GSM549140patient 044, cancer, homogenized [OPG study]9.272590
GSM549111patient 047, normal, homogenized [OPG study]8.176182
GSM549113patient 057, normal, homogenized [OPG study]8.5592485
GSM549132patient 031, cancer, homogenized [OPG study]8.233483
GSM549137patient 038, cancer, homogenized [OPG study]9.3410791
GSM549142patient 047, cancer, homogenized [OPG study]8.1965386
GSM549100patient 110, normal, homogenized [OPG study]7.0601273
GSM549107patient 135, normal, homogenized [OPG study]7.6261378
GSM549115patient 068, normal, homogenized [OPG study]7.0172671
GSM549116patient 072, normal, homogenized [OPG study]8.2194783
GSM549120patient 078, normal, homogenized [OPG study]6.8692870
GSM549131patient 030, cancer, homogenized [OPG study]8.2135382
GSM549118patient 074, normal, homogenized [OPG study]7.1562673
GSM549129patient 027, cancer, homogenized [OPG study]9.455192
GSM549123patient 088, normal, homogenized [OPG study]7.9778581
GSM549124patient 006, cancer, homogenized [OPG study]7.7610480
GSM549126patient 015, cancer, homogenized [OPG study]8.18183
GSM549128patient 025, cancer, homogenized [OPG study]8.9937189
GSM549103patient 117, normal, homogenized [OPG study]7.2240975
GSM549117patient 073, normal, homogenized [OPG study]7.6118578
GSM549138patient 041, cancer, homogenized [OPG study]8.6917386
GSM549141patient 045, cancer, homogenized [OPG study]10.133695
GSM549130patient 028, cancer, homogenized [OPG study]8.2597784
GSM549101patient 111, normal, homogenized [OPG study]7.8419780
GSM549105patient 128, normal, homogenized [OPG study]7.8726581
GSM549106patient 134, normal, homogenized [OPG study]8.8964387
GSM549112patient 048, normal, homogenized [OPG study]8.1595882
GSM549125patient 011, cancer, homogenized [OPG study]7.4319476
GSM549127patient 024, cancer, homogenized [OPG study]8.4366285
GSM549135patient 035, cancer, homogenized [OPG study]7.3911975